分类:
NK细胞
6-5-2024
Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy‐Refractory Biliary Tract Cancer: A Multicenter Open‐Label Phase 1/2a Trial
NK细胞
,
临床文献
,
免疫细胞
,
肿瘤
,
胆道癌
6-5-2024
Frequency and Implications of Natural Killer and Natural Killer ‘T Cells in Hepatocellular Carcinoma
NKT细胞
,
NK细胞
,
临床文献
,
免疫细胞
,
肝癌
,
肿瘤
6-5-2024
Adoptive Transfer of Autologous Invariant Natural Killer T Cells asImmunotherapy for Advanced Hepatocellular Carcinoma: A PhaseI Clinical Trial
NKT细胞
,
NK细胞
,
临床文献
,
免疫细胞
,
肝癌
,
肿瘤
6-5-2024
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
NKT细胞
,
NK细胞
,
临床文献
,
免疫细胞
,
肝癌
,
肿瘤
6-5-2024
Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma
NKT细胞
,
NK细胞
,
临床文献
,
肝癌
,
肿瘤
6-5-2024
The role of natural killer cells in hepatocellular carcinoma development and treatment:A narrative review
NKT细胞
,
NK细胞
,
临床文献
,
肝癌
,
肿瘤
6-5-2024
Characterization of age-related immune features afterautologous NK cell infusion:Protocol for an open-label and randomized controlled trial
NK细胞
,
临床文献
,
免疫细胞
,
延缓衰老
,
细胞衰老
6-5-2024
Effect of autologous NK cell immunotherapy on advanced lung adenocarcinoma with EGFR mutations
NK细胞
,
临床文献
,
免疫细胞
,
肺腺癌
,
肿瘤
6-5-2024
Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients
NK细胞
,
临床文献
,
肺癌
6-4-2024
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
NK细胞
,
临床文献
,
延缓衰老
←
上一页
下一页
→